SomaLogic, Inc. (SLGC) reported Q2 EPS of ($0.13), $0.03 better than the analyst estimate of ($0.16). Revenue for the quarter came in at $14.1 million versus the consensus estimate of $24.83 million.
GUIDANCE:
SomaLogic, Inc. sees FY2022 revenue of $80-90 million, versus the consensus of $106.95 million.